Clinical trials: Gastrointestinal Tolerance of Dietary Fiber
- Condition Gastrointestinal Tolerance of Dietary Fiber
- Funder type Industry (pharma, biotech, devices)
Gastrointestinal Tolerance
A Study Assessing the Tolerable Upper Intake Level and Safety of Sugars From Fiber
The purpose of this study is to determine the upper tolerable limit of Sugars from Fiber
- Trial name
- NCT05051202
- Testing
- Sugars from Fiber, Resistant Maltodextrin
- Where
- Ireland
- Volunteers
- 29 people, healthy volunteers welcome
- Sponsor
- Cambridge Glycoscience
Gastrointestinal Tolerance of Dietary Fiber
Fiber Tolerance Study
Research shows that many people do not get enough dietary fiber through their normal diet. As a result, some nutrients are not properly absorbed into the bloodstream. The immune system however does need these nutrients.
- Trial name
- Gitomix (NCT06115057)
- Testing
- Fiber
- Where
- Netherlands
- Volunteers
- 43 people, healthy volunteers welcome
- Sponsor
- Nutricia Research
Gastrointestinal Tolerance
The Effects of Soluble Corn Fiber on Gastrointestinal Tolerance and Fecal Microbiome in Healthy Children
The purpose of this study is to compare the effects of PROMITOR® Soluble Corn Fiber versus inulin on GI symptoms (tolerance), stool consistency (laxation) and fecal microbiome at levels that could contribute to closing the fiber…
- Trial name
- NCT05213494
- Testing
- Inulin, soluble corn fiber
- Where
- United States
- Volunteers
- 44 people, healthy volunteers welcome
- Sponsor
- Tate & Lyle
Dietary Exposure
Acceptability and Tolerance Study of Peptide Feed with Fibre
Enterally fed adults with documented evidence of gastrointestinal intolerance will be recruited. Participants will be deemed by the investigator as having a clinical indication for enteral feeding with a fibre containing peptide…
- Trial name
- NCT06102135
- Testing
- Peptamen 1.3 PHGG
- Where
- 2 sites in United Kingdom
- Volunteers
- 15 people
- Sponsor
- Société des Produits Nestlé (SPN)
Gastrointestinal Tolerance
A Double Blind Study on the Gastrointestinal Effects of Arabinoxylan (Leaf Fiber Extract).
The objective of this study is to investigate the effect on Arabinoxylan on gastrointestinal (GI) tolerance, bowel habits, and microbiota in adults.
- Trial name
- NCT04100460
- Testing
- 7.25 grams of Arabinoxylan leaf fiber extract, 14.5 grams of Arabinoxylan leaf fiber extract, Control - No Arabinoxylan
- Volunteers
- 45 people, healthy volunteers welcome
- Sponsor
- Comet Bio Inc.